Niamh Louise Pellegrini

CIK 1620611 · Chief Commercial Officer · last filed 2023-06-15

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

27

Lifetime Open-Market Net

-$1.55M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Acutus Medical, Inc. (AFIB) Delisted Director 20,972 $0.09 $1.9K $0 3 2023-06-15
NEVRO CORP (NVRO) Delisted Chief Commercial Officer 85,967 $5.84 $502.0K -$1.55M 21 2023-05-31
THORATEC CORP (THOR) Delisted President, North America 51,928 $0 3 2015-10-08

Recent Filings · Page 3 of 3

27 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-09-14 NEVRO CORP (NVRO) Delisted Mixed -$55.6K EDGAR
2020-08-10 NEVRO CORP (NVRO) Delisted Mixed −4,476 -$690.9K EDGAR
2020-03-04 NEVRO CORP (NVRO) Delisted Grant (A) +5,446 $0 EDGAR
2019-07-17 NEVRO CORP (NVRO) Delisted Grant (A) +33,175 $0 EDGAR
2015-10-08 THORATEC CORP (THOR) Delisted Mixed −40,700 -$3.30M EDGAR
2015-03-16 THORATEC CORP (THOR) Delisted Grant (A) +13,099 $0 EDGAR
2014-10-15 THORATEC CORP (THOR) Delisted Grant (A) +27,601 $0 EDGAR
Showing 2127 of 27
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.